ICM0201, a new inhibitor of osteoclastogenesis from Cunninghamella sp. F-1490. I. Taxonomy, fermentation, isolation and biological activities.

@article{Inoue2003ICM0201AN,
  title={ICM0201, a new inhibitor of osteoclastogenesis from Cunninghamella sp. F-1490. I. Taxonomy, fermentation, isolation and biological activities.},
  author={Hiroyuki Inoue and Hiroyuki Kumagai and Michiyo Osono and Motoko Matsufuji and Tomohiro Sameshima and Naoto Kawamura and Tetsuya Someno and Masaaki Ishizuka and Tomio Takeuchi},
  journal={The Journal of antibiotics},
  year={2003},
  volume={56 3},
  pages={
          209-13
        }
}
In the course of screening for inhibitors of osteoclastogenesis, a new substance designated as ICM0201 was isolated from a fermentation broth of Cunninghamella sp. F-1490. ICM0201 inhibited the formation of osteoclasts in mouse bone marrow cells with an IC50 value of 0.78 microg/ml and showed weak cytotoxicity against bone marrow cells. 
ICM0201, a new inhibitor of osteoclastogenesis from Cunninghamella sp. F-1490. II. Structure determination and synthesis.
TLDR
The structure of ICM0201 was determined to be (3S,10aR)-3, 4a-dihydroxy-2,3,4,4a-tetrahydro-2H-pyrano[3,2-b]benzo[e]morpholine-9-carboxylic acid by spectroscopic analyses and chemical studies.
Small-molecule natural products: new structures, new activities.
Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology
TLDR
Recent advances in the chemistry and analysis of inhibitors of prostaglandin release or other functional molecules of immune cells, as well as inducers of osteoblast differentiation are described, including biological and pharmacological activities.

References

SHOWING 1-10 OF 24 REFERENCES
ICM0201, a new inhibitor of osteoclastogenesis from Cunninghamella sp. F-1490. II. Structure determination and synthesis.
TLDR
The structure of ICM0201 was determined to be (3S,10aR)-3, 4a-dihydroxy-2,3,4,4a-tetrahydro-2H-pyrano[3,2-b]benzo[e]morpholine-9-carboxylic acid by spectroscopic analyses and chemical studies.
Antibiotics produced by Streptomyces ficellus II. Feldamycin and nojirimycin.
TLDR
A new antibacterial agent and nojirimycin have been isolated from cultures of Streptomyces ficellus, and an amphoteric compound which inhibits a variety of bacteria in vitro is found to be ineffective in the treatment of experimental bacterial infections in mice.
Delaminomycins, novel extracellular matrix receptor antagonist. III. Physico-chemical properties and structure elucidation of delaminomycins B and C.
TLDR
The physico-chemical properties and structural elucidation of two components, delaminomycins B and C, are reported, which inhibited the binding of Con A stimulated-EL4 cells to FN and LM components of ECM2.
Isolation and structure of a new polyether antibiotic, octacyclomycin.
In the course of a screening program for novel antibiotics showing antitumor activity, a cyclic peptide antibiotic sohbumycin was isolated from the culture broth of Streptomyces sp. No. 82-85, which
Macrophage-stimulating protein (MSP) and its receptor, RON, stimulate human osteoclast activity but not proliferation: effect of MSP distinct from that of hepatocyte growth factor.
TLDR
It is concluded that the MSP signal transduction pathway plays a role in bone resorption that is distinct from that of HGF.
Effect of prostaglandins E1, E2, and F2α on osteoclast formation in mouse bone marrow cultures
TLDR
The results suggest that PGE1 and E2 induce osteoclastic differentiation in mouse bone marrow cultures and inhibit the function of the osteoclasts thus formed.
1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow.
TLDR
The data suggest that the multinucleated cells in the authors' culture have several characteristics of osteoclasts and that the potent bone-resorbing activity of 1,25-dihydroxyvitamin D3 in vivo and in vitro may be mediated in part by stimulation of marrow mononuclear cells to form osteoclast.
Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures.
TLDR
The results suggest that committed mononuclear osteoclast precursors are derived from CFU-GM, the committed granulocyte-macrophage progenitor, have a distinct polygonal morphology and cross-react with monoclonal antibodies that recognize mature osteoclasts and are capable of forming multinucleated cells which fulfill the functional criteria for osteoclast.
Modulation of osteoclast differentiation.
TLDR
Osteotropic hormones such as 1α, 25-dihydroxyvitamin D3 [1α,25(OH)2D3], PTH, and calcitonin preferentially modulate the process of bone resorption to maintain bone remodeling.
...
...